120 related articles for article (PubMed ID: 30745320)
1. The Role of ACKR3 in Breast, Lung, and Brain Cancer.
Neves M; Fumagalli A; van den Bor J; Marin P; Smit MJ; Mayor F
Mol Pharmacol; 2019 Dec; 96(6):819-825. PubMed ID: 30745320
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
Silwedel C; Speer CP; Haarmann A; Fehrholz M; Claus H; Buttmann M; Glaser K
J Neuroinflammation; 2018 May; 15(1):156. PubMed ID: 29792190
[TBL] [Abstract][Full Text] [Related]
4. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System.
Koenen J; Bachelerie F; Balabanian K; Schlecht-Louf G; Gallego C
Mol Pharmacol; 2019 Dec; 96(6):809-818. PubMed ID: 31040166
[TBL] [Abstract][Full Text] [Related]
5. C-X-C Chemokine Receptor Type 7 (CXCR-7) Expression in Invasive Ductal Carcinoma of Breast in Association with Clinicopathological Features.
Shams R; Seifi-Alan M; Bandehpour M; Omrani MD; Ghafouri-Fard S
Pathol Oncol Res; 2020 Apr; 26(2):1015-1020. PubMed ID: 30955173
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
[TBL] [Abstract][Full Text] [Related]
7. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
[TBL] [Abstract][Full Text] [Related]
10. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.
Inaguma S; Riku M; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2015 Oct; 6(32):33648-57. PubMed ID: 26413813
[TBL] [Abstract][Full Text] [Related]
11. Role of the blood-brain barrier in the formation of brain metastases.
Wilhelm I; Molnár J; Fazakas C; Haskó J; Krizbai IA
Int J Mol Sci; 2013 Jan; 14(1):1383-411. PubMed ID: 23344048
[TBL] [Abstract][Full Text] [Related]
12. Ackr3-Venus knock-in mouse lights up brain vasculature.
Ehrlich AT; Semache M; Couvineau P; Wojcik S; Kobayashi H; Thelen M; Gross F; Hogue M; Le Gouill C; Darcq E; Bouvier M; Kieffer BL
Mol Brain; 2021 Sep; 14(1):151. PubMed ID: 34583741
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of ligand interaction with atypical chemokine receptor 3.
Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
[TBL] [Abstract][Full Text] [Related]
14. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
[TBL] [Abstract][Full Text] [Related]
16. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
Fumagalli A; Zarca A; Neves M; Caspar B; Hill SJ; Mayor F; Smit MJ; Marin P
Mol Pharmacol; 2019 Dec; 96(6):794-808. PubMed ID: 30837297
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CXCR7 is an independent prognostic biomarker in glioblastoma.
Deng L; Zheng W; Dong X; Liu J; Zhu C; Lu D; Zhang J; Song L; Wang Y; Deng D
Cancer Biomark; 2017 Jul; 20(1):1-6. PubMed ID: 28759950
[TBL] [Abstract][Full Text] [Related]
18. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Miao Z; Luker KE; Summers BC; Berahovich R; Bhojani MS; Rehemtulla A; Kleer CG; Essner JJ; Nasevicius A; Luker GD; Howard MC; Schall TJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15735-40. PubMed ID: 17898181
[TBL] [Abstract][Full Text] [Related]
19. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Jung YY; Kim HM; Koo JS
PLoS One; 2015; 10(9):e0137204. PubMed ID: 26334757
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
